• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环外泌体长链非编码 RNA H19 作为胃癌潜在的新型诊断和预后生物标志物。

Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer.

机构信息

Department of Clinical Laboratory, The Affiliated Hospital of Jiaxing University, Jiaxing, China.

出版信息

J Int Med Res. 2020 Jul;48(7):300060520934297. doi: 10.1177/0300060520934297.

DOI:10.1177/0300060520934297
PMID:32660285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7361491/
Abstract

OBJECTIVE

Long non-coding RNAs (lncRNAs) are involved in carcinogenesis and could be used as diagnostic biomarkers. Our study aimed to elucidate the clinical role of serum exosomal lncRNA H19 in gastric cancer (GC).

METHODS

In this prospective clinical study, we determined serum exosomal lncRNA H19 levels in 81 patients with GC and analysed the correlations between serum lncRNA H19 levels and clinical characteristics. Receiver operating characteristics (ROC) curves were constructed to determine the diagnostic performance of exosomal lncRNA H19 in GC.

RESULTS

Serum exosomal lncRNA H19 levels were significantly upregulated in patients with GC both before and after surgery compared with healthy controls. Furthermore, serum exosomal lncRNA H19 levels were significantly decreased after compared with before surgery in patients with GC. Preoperative lncRNA H19 levels were significantly correlated with TNM stage. The area under the ROC curve (AUC) value for exosomal lncRNA H19 was 0.849, which was significantly higher than the AUC values for cancer antigens 19-9 and 72-4 and carcinoembryonic antigen, either alone or combined.

CONCLUSIONS

These results suggest that circulating exosomal lncRNA H19 may be a potential biomarker with diagnostic and prognostic value in GC.

摘要

目的

长链非编码 RNA(lncRNA)参与癌症的发生,可作为诊断生物标志物。本研究旨在阐明血清外泌体 lncRNA H19 在胃癌(GC)中的临床作用。

方法

在这项前瞻性临床研究中,我们测定了 81 例 GC 患者的血清外泌体 lncRNA H19 水平,并分析了血清 lncRNA H19 水平与临床特征之间的相关性。绘制受试者工作特征(ROC)曲线以确定外泌体 lncRNA H19 在 GC 中的诊断性能。

结果

GC 患者术前和术后血清外泌体 lncRNA H19 水平均明显高于健康对照组。此外,GC 患者术后血清外泌体 lncRNA H19 水平明显低于术前。术前 lncRNA H19 水平与 TNM 分期显著相关。外泌体 lncRNA H19 的 ROC 曲线下面积(AUC)值为 0.849,明显高于单独或联合使用癌抗原 19-9、72-4 和癌胚抗原的 AUC 值。

结论

这些结果表明,循环外泌体 lncRNA H19 可能是 GC 具有诊断和预后价值的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/7361491/f3fb9a0b374d/10.1177_0300060520934297-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/7361491/44955751e22c/10.1177_0300060520934297-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/7361491/48dc58f2e656/10.1177_0300060520934297-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/7361491/b99f90f5f4d6/10.1177_0300060520934297-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/7361491/f3fb9a0b374d/10.1177_0300060520934297-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/7361491/44955751e22c/10.1177_0300060520934297-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/7361491/48dc58f2e656/10.1177_0300060520934297-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/7361491/b99f90f5f4d6/10.1177_0300060520934297-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e29a/7361491/f3fb9a0b374d/10.1177_0300060520934297-fig4.jpg

相似文献

1
Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer.循环外泌体长链非编码 RNA H19 作为胃癌潜在的新型诊断和预后生物标志物。
J Int Med Res. 2020 Jul;48(7):300060520934297. doi: 10.1177/0300060520934297.
2
Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.循环外泌体胃癌相关长非编码 RNA1 作为胃癌早期检测和监测进展的生物标志物:一项多阶段研究。
JAMA Surg. 2020 Jul 1;155(7):572-579. doi: 10.1001/jamasurg.2020.1133.
3
H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.H19 可作为诊断生物标志物,H19 表达上调与胃癌患者预后不良有关。
Neoplasma. 2016;63(2):223-30. doi: 10.4149/207_150821N454.
4
Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer.循环长链非编码RNA H19作为胃癌患者血浆中有前景的新型生物标志物的作用评估
J Clin Lab Anal. 2016 Nov;30(6):1100-1105. doi: 10.1002/jcla.21987. Epub 2016 May 17.
5
Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer.血浆中长链非编码RNA H19作为胃癌诊断新生物标志物的鉴定。
Sci Rep. 2015 Jun 22;5:11516. doi: 10.1038/srep11516.
6
Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.血清外泌体 H19 作为膀胱癌诊断和预后的无创生物标志物的测定。
Med Sci Monit. 2018 Dec 21;24:9307-9316. doi: 10.12659/MSM.912018.
7
Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer.外泌体长链非编码 RNA lnc-GNAQ-6:1 可作为胃癌的诊断标志物。
Clin Chim Acta. 2020 Feb;501:252-257. doi: 10.1016/j.cca.2019.10.047. Epub 2019 Nov 12.
8
Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer.血清外泌体长链非编码 RNA SNHG15 表达升高预示非小细胞肺癌不良预后。
J Clin Lab Anal. 2021 Nov;35(11):e23979. doi: 10.1002/jcla.23979. Epub 2021 Sep 22.
9
Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.血浆中循环lncRNA H19作为乳腺癌的一种新型生物标志物。
Cancer Biomark. 2016 Jun 24;17(2):187-94. doi: 10.3233/CBM-160630.
10
Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer.血清外泌体长链非编码RNA MIAT作为胃癌新型诊断和预后生物标志物的鉴定。
J Clin Lab Anal. 2020 Aug;34(8):e23323. doi: 10.1002/jcla.23323. Epub 2020 Apr 10.

引用本文的文献

1
Diagnostic and prognostic significance of circulating extracellular vesicles in gastrointestinal cancers.循环细胞外囊泡在胃肠道癌症中的诊断和预后意义
Clin Transl Oncol. 2025 Sep 12. doi: 10.1007/s12094-025-04055-0.
2
Role of circulating tumor DNA methylation in gastric cancer initiation and progression: A comprehensive review.循环肿瘤DNA甲基化在胃癌发生和发展中的作用:综述
World J Gastrointest Oncol. 2025 Aug 15;17(8):107412. doi: 10.4251/wjgo.v17.i8.107412.
3
Altered Levels of and in Exosomes of Patients Recently Diagnosed With Acute Lymphoblastic Leukemia.

本文引用的文献

1
Exosomes in gastric cancer: roles, mechanisms, and applications.胃癌中的细胞外囊泡:作用、机制与应用。
Mol Cancer. 2019 Mar 15;18(1):41. doi: 10.1186/s12943-019-1001-7.
2
Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.血清外泌体 H19 作为膀胱癌诊断和预后的无创生物标志物的测定。
Med Sci Monit. 2018 Dec 21;24:9307-9316. doi: 10.12659/MSM.912018.
3
RETRACTED: Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma.
近期诊断为急性淋巴细胞白血病患者外泌体中[具体物质]水平的改变
In Vivo. 2025 Jul-Aug;39(4):1941-1964. doi: 10.21873/invivo.13993.
4
Diagnostic value of exosome non-coding RNAs as non-invasive biomarkers in gastric cancer: a meta-analysis.外泌体非编码RNA作为胃癌无创生物标志物的诊断价值:一项荟萃分析
Front Oncol. 2025 Jun 12;15:1570020. doi: 10.3389/fonc.2025.1570020. eCollection 2025.
5
Functions and Clinical Applications of Exosomes in Gastric Cancer.外泌体在胃癌中的功能及临床应用
Int J Biol Sci. 2025 Feb 28;21(5):2330-2345. doi: 10.7150/ijbs.98087. eCollection 2025.
6
Exosome-Based Theranostic for Gastrointestinal Cancer: Advances in Biomarker Discovery and Therapeutic Engineering.基于外泌体的胃肠道癌诊疗:生物标志物发现与治疗工程进展
Small Methods. 2025 Feb 25:e2402058. doi: 10.1002/smtd.202402058.
7
Diagnostic and Prognostic Significance of Exosomes and Their Components in Patients With Cancers.外泌体及其成分在癌症患者中的诊断和预后意义
Cancer Med. 2025 Jan;14(1):e70569. doi: 10.1002/cam4.70569.
8
Liquid biopsy in cancer current: status, challenges and future prospects.癌症液体活检的现状、挑战与未来前景
Signal Transduct Target Ther. 2024 Dec 2;9(1):336. doi: 10.1038/s41392-024-02021-w.
9
The Role of Long Non-Coding RNAs in Ovarian Cancer Cells.长链非编码 RNA 在卵巢癌细胞中的作用。
Int J Mol Sci. 2024 Sep 14;25(18):9922. doi: 10.3390/ijms25189922.
10
Exosomal long non-coding RNAs in cancer: Interplay, modulation, and therapeutic avenues.癌症中的外泌体长链非编码RNA:相互作用、调控及治疗途径
Noncoding RNA Res. 2024 Apr 4;9(3):887-900. doi: 10.1016/j.ncrna.2024.03.014. eCollection 2024 Sep.
撤回:长链非编码 RNA-H19 通过 microRNA-143/RUNX2 轴抑制视网膜母细胞瘤细胞活力、迁移和侵袭,同时促进细胞凋亡。
Biomed Pharmacother. 2019 Jan;109:798-805. doi: 10.1016/j.biopha.2018.10.096. Epub 2018 Nov 5.
4
Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer.肿瘤释放的长链非编码 RNA H19 通过包裹到非小细胞肺癌的外泌体中促进吉非替尼耐药。
Oncol Rep. 2018 Dec;40(6):3438-3446. doi: 10.3892/or.2018.6762. Epub 2018 Oct 3.
5
Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.癌相关成纤维细胞通过转移外泌体 lncRNA H19 促进结直肠癌细胞的干性和化疗耐药性。
Theranostics. 2018 Jun 24;8(14):3932-3948. doi: 10.7150/thno.25541. eCollection 2018.
6
Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer.环状 RNA-miRNA-mRNA 调控网络参与胃癌的组织学分类和疾病进展。
J Transl Med. 2018 Aug 2;16(1):216. doi: 10.1186/s12967-018-1582-8.
7
New insights into the biological impacts of immune cell-derived exosomes within the tumor environment.免疫细胞衍生的外泌体在肿瘤微环境中的生物学作用的新见解。
Cancer Lett. 2018 Sep 1;431:115-122. doi: 10.1016/j.canlet.2018.05.040. Epub 2018 May 30.
8
LncRNA H19/miR-29b-3p/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling.LncRNA H19/miR-29b-3p/PGRN 轴通过作用于 Wnt 信号通路促进结直肠癌细胞上皮-间质转化。
Mol Cells. 2018 May 31;41(5):423-435. doi: 10.14348/molcells.2018.2258. Epub 2018 May 10.
9
Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer.肿瘤来源的外泌体 lncUEGC1 作为早期胃癌的循环生物标志物。
Mol Cancer. 2018 Apr 24;17(1):84. doi: 10.1186/s12943-018-0834-9.
10
Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p.长链非编码 RNA H19 通过抑制 miR-199a-5p 上调血管内皮生长因子 A 以增强间充质干细胞的存活和血管生成能力。
Stem Cell Res Ther. 2018 Apr 19;9(1):109. doi: 10.1186/s13287-018-0861-x.